Optimal timing of surgery after neoadjuvant treatment in borderline resectable pancreatic cancer.
Hye-Sol JungWooil KwonWon-Gun YunWoo Hyun PaikSang Hyub LeeJi-Kon RyuDo-Youn OhKyoung Bun LeeEui Kyu ChieJin-Young JangPublished in: Journal of hepato-biliary-pancreatic sciences (2024)
The optimal resection timing following NAT is once a patient undergoes at least 3 months of neoadjuvant chemotherapy or at least eight FOLFIRINOX cycles.